Background/PurposeIt has been reported that gonadotropin releasing hormone analogue (GnRHa) therapy can improve the adult height of patients with gonadotropin-dependent precocious puberty. The purpose of this study was to evaluate the effect of GnRHa on the adult height of girls with gonadotropin-dependent precocious puberty and the adverse effects of such therapy.MethodsBetween 1989 and 2006, 11 girls with gonadotropin-dependent precocious puberty who had been treated with GnRHa and reached their adult height were enrolled in the present study. Follow-up studies of bone age, pelvic sonography and GnRH test were done regularly during the period of treatment. All patients had bone mineral density examined at least 2 years after completion of...
Objectives: To study the effect of gonadotropin-releasing hormone analogue (GnRHa) on final adult he...
Idiopathic central precocious puberty may compromise adult height. Gonadotrophin-releasing hormone a...
GnRH analogues (GnRHa) are the treatment of choice for central precocious puberty (CPP), with the ma...
Background/PurposeIt has been reported that gonadotropin releasing hormone analogue (GnRHa) therapy ...
It has been reported that gonadotropin releasing hormone analogue (GnRHa) therapy can improve the ad...
BACKGROUND/PURPOSE: It has been reported that gonadotropin releasing hormone analogue (GnRHa) therap...
PurposeTo investigate the effectiveness and safety of gonadotropin-releasing hormone analogue (GnRHa...
Gonadotropin-releasing hormone analogs (GnRHa) are widely used to treat central precocious puberty (...
Objective: We assessed in a retrospective unicenter study the impact of treatment with GnRH analogs ...
PURPOSE: There is controversy surrounding the growth outcomes of treatment with gonadotropin-releasi...
Aim:Gonadotropin-releasing hormone agonists (GnRHa) are widely used in the treatment of central prec...
GnRH analogs (GnRHa) arrest pubertal development and slow growth velocity (GV) and bone maturation, ...
PurposeThe potential effect of gonadotropin-releasing hormone agonist (GnRHa) treatment on the weigh...
Object To study the outcomes of GnRHa on final adult height in Chinese idiopathic central precocious...
OBJECTIVE:Gonadotropin-releasing hormone agonists (GnRHa) are the treatment of choice for central pr...
Objectives: To study the effect of gonadotropin-releasing hormone analogue (GnRHa) on final adult he...
Idiopathic central precocious puberty may compromise adult height. Gonadotrophin-releasing hormone a...
GnRH analogues (GnRHa) are the treatment of choice for central precocious puberty (CPP), with the ma...
Background/PurposeIt has been reported that gonadotropin releasing hormone analogue (GnRHa) therapy ...
It has been reported that gonadotropin releasing hormone analogue (GnRHa) therapy can improve the ad...
BACKGROUND/PURPOSE: It has been reported that gonadotropin releasing hormone analogue (GnRHa) therap...
PurposeTo investigate the effectiveness and safety of gonadotropin-releasing hormone analogue (GnRHa...
Gonadotropin-releasing hormone analogs (GnRHa) are widely used to treat central precocious puberty (...
Objective: We assessed in a retrospective unicenter study the impact of treatment with GnRH analogs ...
PURPOSE: There is controversy surrounding the growth outcomes of treatment with gonadotropin-releasi...
Aim:Gonadotropin-releasing hormone agonists (GnRHa) are widely used in the treatment of central prec...
GnRH analogs (GnRHa) arrest pubertal development and slow growth velocity (GV) and bone maturation, ...
PurposeThe potential effect of gonadotropin-releasing hormone agonist (GnRHa) treatment on the weigh...
Object To study the outcomes of GnRHa on final adult height in Chinese idiopathic central precocious...
OBJECTIVE:Gonadotropin-releasing hormone agonists (GnRHa) are the treatment of choice for central pr...
Objectives: To study the effect of gonadotropin-releasing hormone analogue (GnRHa) on final adult he...
Idiopathic central precocious puberty may compromise adult height. Gonadotrophin-releasing hormone a...
GnRH analogues (GnRHa) are the treatment of choice for central precocious puberty (CPP), with the ma...